About Haemotronic
Haemotronic is a Healthcare company based in Mirandola (Italy) founded in 1999, and was acquired by GVS in May 2022. Medical components for healthcare are manufactured in Italy since 1999. Haemotronic has completed 1 acquisition, including Aguettant. Its chief executive, as recorded, is Mattia Ravizza. Its focus areas include Traditional Medical Devices and Medical Device Outsourcing.
Company details
Haemotronic was established in 1999 in Mirandola, Italy, as a manufacturer of medical components. Precision parts for medical devices are produced, with operations centered on the healthcare sector. Components are designed and assembled to meet regulatory standards, supporting applications in diagnostics and treatment. The firm is headed by CEO Mattia Ravizza, and activities remain focused on European markets with potential for global supply.
- Headquarters Mirandola, Italy
- Stage Acquired
- SectorsHealthcare
- Website haemotronic.it
- Social LinkedIn
- Acquired by GVS (May 2022)
- Latest Funding Round$255.85K (USD), Grant
Nov 2020
- InvestorsGVS Filter Technology
& 1 more
- Investments & Acquisitions
- Acquired byGVS
(May 2022)
Funding Insights of Haemotronic
- Total Rounds 1
- Last Round Grant — $255,848
- First Round $255,848
(Nov 2020)
- Investors Count 1
All 1 funding rounds of Haemotronic with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2020 | $255,848 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Haemotronic
Haemotronic has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include GVS Filter Technology and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Filtration solutions are provided by GVS for multiple industries. | 1979 | gvs.com | Bologna, Italy |
Investor details for Haemotronic
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Haemotronic
1 people are tracked at Haemotronic (1 in leadership).
| Name | Role | Group |
|---|---|---|
Mattia Ravizza | CEO | Leadership |
Complete people profiles for Haemotronic
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Haemotronic
Haemotronic has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Aguettant.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Humus-based fertilizers and soil conditioners are manufactured for soil enhancement. | aguettant-corporate.com | Lyon, France | 1903 | Dec 2001 | •••• |
Complete acquisition details for Haemotronic
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Web traffic of Haemotronic
Websites that share an audience with Haemotronic (haemotronic.it).
Websites whose visitors overlap most with Haemotronic. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
gardosiricambi.it | gardosiricambi.it | 100% | – | ||
polmac.it | polmac.it | 100% | – | ||
x2manufacturing.it | x2manufacturing.it | 100% | – | ||
quantobasta.shop | quantobasta.shop | 100% | – | ||
officinaesseti.it | officinaesseti.it | 100% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 20 similar websites and full traffic analytics for Haemotronic
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 20 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Haemotronic
Complete news archive for Haemotronic
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Haemotronic
Haemotronic was founded in 1999 and raised its 1st funding round 21 years after it was founded.
Haemotronic is headquartered in Mirandola, Italy. It is registered at Mirandola, Emilia-romagna, Italy.
Mattia Ravizza is the CEO of Haemotronic, as recorded in our data.
Haemotronic was established in 1999 in Mirandola, Italy, as a manufacturer of medical components. Precision parts for medical devices are produced, with operations centered on the healthcare sector. Components are designed and assembled to meet regulatory standards, supporting applications in diagnostics and treatment. The firm is headed by CEO Mattia Ravizza, and activities remain focused on European markets with potential for global supply.
Haemotronic has made 1 acquisition, including Aguettant.
Haemotronic has 2 investors. Key investors include GVS Filter Technology, and European Union.
Yes. Haemotronic was acquired by GVS in May 2022.